These compounds may interact with:
PC4 and SFRS1-interacting protein
Potentially involved in: carcinoma; acquired immunodeficiency syndrome; cancer; interstitial cystitis; hypersensitivity reaction type ii disease; leukemia, myelocytic, acute; adult high grade glioma; astrocytic glioma; atypical teratoid / rhabdoid tumor; dermatomyositis; down syndrome; ependymoma; glioblastoma; group 3 medulloblastoma; hepatocellular carcinoma; invasive ductal carcinoma; lung adenocarcinoma; lung cancer; malignant mesothelioma; medulloblastoma, large-cell
Disease data sourced from Pharos.